Cell Analysis Global Market - Forecast to 2025

Publishing Date : August, 2019
Report Code : HCBT0103
Price:
Single license $4,950
Site license $6,750
Global license $9,000


 

Cells are the biological units that are used for the identification and mapping of the basic biochemical and physical processes of life. Analysis of these cells plays a major role in gene identification, protein identification, transcription analysis and epigenomics at the cellular level by revealing the heterogeneity of the cells. Hospitals, academic institutions, government institutes, as well as pharmaceutical and biotechnology firms are increasing their focus on the application of cell analysis as an important tool in research, drug discovery and diagnosis. According to IQ4I analysis, the cell analysis global market is expected to reach $39,322.3 million by 2025 growing at a high single digit CAGR from 2018 to 2025.

The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into molecular approaches and image-based approach where the molecular approach commanded the largest market and is expected to grow at a high single digit CAGR.

The molecular approaches include the PCR, sequencing techniques, microarray and microfluidics, cell isolation and separation techniques performed at cells genomic level. Among molecular approaches PCR accounted for the largest share in 2018. The image-based approach is segmented into microscopy, cytometry, high content screening, and Spectrophotometers. Among image-based approaches Cytometry generated the largest revenue in 2018.

The cell analysis products market is mainly segmented into consumables, instruments, software and services. The consumables include reagents, assay kits, microplates, cell culture consumables and others. Among these consumables commanded the largest market in 2018. The instrument segment comprises of cell counters, Cell microarray and microfluidics, liquid handling systems, cytometers, microfluidic devices, high content screening (HCS) systems microplate readers, PCR devices, sequencing instruments, spectrophotometer, microscopes and others. Among instruments, The PCR instruments commanded the largest share in 2018.Sequencing is expected to grow at a high single digit CAGR from 2018 to 2025 due to increasing adoption of sequencing technology in various life science research areas and decreasing cost of genome sequencing.

By application, the market is categorized by processes, by field, and by therapeutic area. In the process of application, market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single-cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening. Cellular process application accounted for the largest revenue in 2018 and the Circulating tumor cell analysis market is expected to boom at double digit CAGR from 2018 to 2025. By field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics held the largest revenue in 2018 and stem cell analysis is expected to grow at a double digit CAGR from 2018 to 2025. The cell imaging market is further segmented into live-cell imaging which is expected to grow at high single digit CAGR. By therapeutic area, the market is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, and others. The Cancer research accounted for the largest revenue in 2018.

The end-users, the market is segmented into hospitals, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, diagnostic laboratories and others. Academic and research institutes generated the largest in 2018, but the Contract Research Organizations are expected to grow at double digit CAGR from 2018 to 2025.By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America held the largest market share in 2018, followed by Europe and Asia. The APAC regions tend to be market with opportunity for growth and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies have resulted in a growth of Asian markets. The rising incidence of life-threatening infectious diseases, increasing funding and investments in cell-based research from government and corporate, availability of advanced cell imaging and analysis systems that reduce the cost and time for drug discovery, availability of advanced cell analysis instruments, high demand for cell analysis products by end-users, emerging Asia-Pacific market, emerging cell analysis service providers and introduction of automation technologies in cancer research are driving the cell analysis market growth. However, stringent government regulations and patent-related issues, lack of skilled personnel to perform advanced cell analysis Instruments, and the high cost of some of the commercial instruments are expected to hamper the market growth.

The cell analysis global market is competitive and all the players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America (U.S. and Rest of North America)
  • Europe (Germany, U.K. France and Rest of Europe)
  • Asia-Pacific (China, Japan, India and Rest of APAC)
  • Rest of the World ( Brazil, Rest of LATAM and Middle East and Others)
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN & DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     RISING INCIDENCE OF LIFE-THREATENING INFECTIOUS DISEASES
        • 3.3.1.2     INCREASING FUNDING AND INVESTMENT IN CELL-BASED RESEARCH
        • 3.3.1.3     INTRODUCTION OF ENHANCED CELL IMAGING SYSTEM REDUCES THE COST AND TIME CONSUMPTION FOR THE DRUG DISCOVERY PROCESS
        • 3.3.1.4     AVAILABILITY OF ADVANCED CELL ANALYSIS INSTRUMENTS
        • 3.3.1.5     INCREASING DEMAND FOR CELL ANALYSIS PRODUCTS BY END-USERS
        • 3.3.1.6     EMERGENCE OF LIQUID BIOPSY TESTS USING SINGLE CELL ANALYSIS
        • 3.3.1.7     EMERGING ASIA PACIFIC CELL ANALYSIS MARKET
        • 3.3.1.8     AVAILABILITY OF CELL ANALYSIS SERVICE PROVIDERS
        • 3.3.1.9     AUTOMATION IN ONCOLOGY RESEARCH FOR EARLY DIAGNOSIS
      • 3.3.2     RESTRAINTS & THREATS
        • 3.3.2.1     LACK OF SKILLED PERSONNEL TO USE ADVANCED CELL ANALYSIS INSTRUMENTS
        • 3.3.2.2     EXPENSIVE CELL ANALYSIS INSTRUMENTS
        • 3.3.2.3     MAINTAINING CONSISTENCY, REPRODUCIBILITY OF ASSAYS AND LACK OF STANDARDIZATION
        • 3.3.2.4     STRINGENT REGULATORY FRAMEWORK LIMITS ADVANCEMENTS IN CELLULAR ANALYSIS MARKET
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     CHINA
      • 3.4.4     INDIA
      • 3.4.5     JAPAN
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     COMPETITIVE RIVALRY
      • 3.5.4     BARGAINING POWER OF SUPPLIERS
      • 3.5.5     BARGAINING POWER OF BUYERS
    • 3.6     LATEST AND UPCOMING PRODUCTS
    • 3.7     ONGOING RESEARCHES AND FUNDING SCENARIO
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     MARKET SHARE ANALYSIS
      • 3.9.1     MARKET SHARE ANALYSIS BY CELL ANALYSIS MAJOR PLAYERS
      • 3.9.2     MARKET SHARE ANALYSIS BY SINGLE-CELL ANALYSIS MAJOR PLAYERS
  • 4     CELL ANALYSIS GLOBAL MARKET, BY TECHNIQUES
    • 4.1     INTRODUCTION
    • 4.2     MOLECULAR APPROACHES
      • 4.2.1     PCR (POLYMERASE CHAIN REACTION)
      • 4.2.2     SEQUENCING
      • 4.2.3     MICROFLUIDICS AND MICROARRAYS
      • 4.2.4     CELL ISOLATION AND SEPARATION
    • 4.3     IMAGE BASED APPROACHES
      • 4.3.1     MICROSCOPY
      • 4.3.2     CYTOMETRY
      • 4.3.3     HIGH CONTENT SCREENING
      • 4.3.4     SPECTROPHOTOMETRY
  • 5     CELL ANALYSIS GLOBAL MARKET, BY PRODUCTS
    • 5.1     INTRODUCTION
    • 5.2     CONSUMABLES
      • 5.2.1     ASSAY KITS
      • 5.2.2     REAGENTS
      • 5.2.3     MICROPLATES
      • 5.2.4     CELL CULTURE CONSUMABLES
      • 5.2.5     OTHERS
    • 5.3     INSTRUMENTS
      • 5.3.1     CELL COUNTERS
      • 5.3.2     CELL MICROARRAYS AND MICROFLUIDICS
      • 5.3.3     LIQUID HANDLING SYSTEMS
      • 5.3.4     CYTOMETERS
      • 5.3.5     HIGH CONTENT SCREENING SYSTEMS
      • 5.3.6     MICROPLATE READERS
      • 5.3.7     PCR INSTRUMENTS
      • 5.3.8     SEQUENCING INSTRUMENTS
      • 5.3.9     SPECTROPHOTOMETERS
      • 5.3.10     MICROSCOPES
      • 5.3.11     OTHER INSTRUMENTS
    • 5.4     SOFTWARE AND SERVICES
  • 6     CELL ANALYSIS GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     CELL ANALYSIS GLOBAL MARKET, BY PROCESS OF APPLICATION
      • 6.2.1     CELLULAR PROCESSES
      • 6.2.2     SIGNAL TRANSDUCTION PATHWAY
      • 6.2.3     CIRCULATING TUMOR CELLS
      • 6.2.4     SINGLE-CELL ANALYSIS
      • 6.2.5     EPIGENETIC TARGET ANALYSIS
      • 6.2.6     SUBPOPULATION CHARACTERIZATION
      • 6.2.7     DRUG AND CANDIDATE SCREENING
    • 6.3     CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION
      • 6.3.1     FORENSICS
      • 6.3.2     THERAPEUTICS
      • 6.3.3     GENOMIC ANALYSIS
      • 6.3.4     STEM CELL ANALYSIS
      • 6.3.5     BIOMARKER RESEARCH
      • 6.3.6     CELL IMAGING
        • 6.3.6.1     LIVE-CELL IMAGING
      • 6.3.7     DIAGNOSTICS
    • 6.4     CELL ANALYSIS GLOBAL MARKET, BY THERAPEUTIC AREA OF APPLICATIONS
      • 6.4.1     CANCER RESEARCH
      • 6.4.2     GENETIC TESTING
      • 6.4.3     INFECTIOUS DISEASES
      • 6.4.4     IMMUNOLOGY
      • 6.4.5     OTHERS
  • 7     CELL ANALYSIS GLOBAL MARKET, BY END-USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     ACADEMIC & RESEARCH LABORATORIES
    • 7.4     DIAGNOSTIC LABORATORIES
    • 7.5     PHARMACEUTICALS AND BIOTECH COMPANIES
    • 7.6     CONTRACT RESEARCH ORGANISATIONS
    • 7.7     CELL BANKS
    • 7.8     OTHERS
  • 8     REGIONAL MARKET ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     UNITED STATES OF AMERICA
      • 8.2.2     REST OF NORTH AMERICA
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     UNITED KINGDOM
      • 8.3.3     FRANCE
      • 8.3.4     REST OF EUROPE
    • 8.4     ASIA PACIFIC
      • 8.4.1     CHINA
      • 8.4.2     JAPAN
      • 8.4.3     INDIA
      • 8.4.4     REST OF APAC
    • 8.5     REST OF THE WORLD
      • 8.5.1     BRAZIL
      • 8.5.2     REST OF LATIN AMERICA
      • 8.5.3     MIDDLE EAST AND AFRICA
  • 9     COMPANY DEVELOPMENTS
    • 9.1     INTRODUCTION
      • 9.1.1     NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL ANALYSIS MARKET PLAYERS
    • 9.2     NEW PRODUCT LAUNCH
    • 9.3     AGREEMENTS, PARTNER SHIPS AND COLLABORATIONS
    • 9.4     ACQUISITIONS
    • 9.5     APPROVAL
    • 9.6     BUSINESS EXPANSION
  • 10     MAJOR PLAYER PROFILES
    • 10.1     AGILENT TECHNOLOGIES, INC.
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     BECTON DICKINSON AND COMPANY
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BIO-RAD LABORATORIES INC.
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     DANAHER CORPORATION
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY.
      • 10.4.6     SWOT ANALYSIS
    • 10.5     GE HEALTHCARE
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     ILLUMINA INC.
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     MERCK KGAA
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     OLYMPUS CORPORATION
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     PERKINELMER, INC.
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.1     PROMEGA CORPORATION
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS
    • 10.11     QIAGEN N V
      • 10.11.1     OVERVIEW
      • 10.11.2     FINANCIALS
      • 10.11.3     PRODUCT PORTFOLIO
      • 10.11.4     KEY DEVELOPMENTS
      • 10.11.5     BUSINESS STRATEGY
      • 10.11.6     SWOT ANALYSIS
    • 10.12     THERMOFISHER SCIENTIFIC INC.
      • 10.12.1     OVERVIEW
      • 10.12.2     FINANCIALS
      • 10.12.3     PRODUCT PORTFOLIO
      • 10.12.4     KEY DEVELOPMENTS
      • 10.12.5     BUSINESS STRATEGY
      • 10.12.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 2     CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 3     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 4     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PROCESS OF APPLICATION (2017-2025) ($MN)
      • TABLE 5     CELL ANALYSIS GLOBAL MARKET REVENUE, BY FIELD OF APPLICATION (2017-2025) ($MN)
      • TABLE 6     CELL ANALYSIS GLOBAL MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2017-2025) ($MN)
      • TABLE 7     CELL ANALYSIS GLOBAL MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 8     CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 9     MOLECULAR BASED CELL ANALYSIS APPROACH GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 10     MOLECULAR BASED CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 11     PCR TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 12     SEQUENCING TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 13     MICROFLUIDICS AND MICROARRAY IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 14     CELL ISOLATION AND SEPARATION IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 15     IMAGE BASED CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 16     IMAGE-BASED CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 17     MICROSCOPY TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 18     CYTOMETRY TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 19     HIGH CONTENT SCREENING CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 20     SPECTROPHOTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 21     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PRODUCTS (2017-2025) ($MN)
      • TABLE 22     CELL ANALYSIS GLOBAL MARKET REVENUE, BY CONSUMABLES (2017-2025) ($MN)
      • TABLE 23     CELL ANALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 24     CELL ANALYSIS ASSAY KITS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 25     CELL ANALYSIS REAGENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 26     CELL ANALYSIS MICROPLATES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 27     CELL CULTURE CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 28     OTHER CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 29     CELL ANALYSIS GLOBAL MARKET REVENUE, BY INSTRUMENTS (2017-2025) ($MN)
      • TABLE 30     CELL ANALYSIS INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 31     CELL COUNTERS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 32     MICROARRAYS AND MICROFLUIDICS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 33     LIQUID HANDLING SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 34     CYTOMETERS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 35     HIGH CONTENT SCREENING GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 36     MICROPLATE READERS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 37     PCR INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 38     SEQUENCING INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 39     SPECTROPHOTOMETERS INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 40     MICROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 41     OTHER INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 42     SOFTWARE AND SERVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 43     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PROCESS OF APPLICATION, (2017-2025) ($MN)
      • TABLE 44     CELLULAR PROCESSES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 45     SIGNAL TRANSDUCTION PATHWAY GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 46     CIRCULATING TUMOR CELLS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 47     SINGLE-CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 48     EPIGENETIC TARGET ANALYSIS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 49     SUBPOPULATION CHARACTERIZATION GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 50     DRUG AND CANDIDATE SCREENING GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 51     CELL ANALYSIS GLOBAL MARKET REVENUE, BY FIELD OF APPLICATION, (2017-2025) ($MN)
      • TABLE 52     FORENSICS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 53     THERAPEUTICS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 54     GENOMIC ANALYSIS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 55     CELL ANALYSIS APPLICATIONS GLOBAL MARKET REVENUE FOR STEM CELL ANALYSIS, BY REGION (2017-2025) ($MN)
      • TABLE 56     BIOMARKER RESEARCH GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 57     CELL IMAGING GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 58     LIVE CELL IMAGING GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 59     DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 60     CELL ANALYSIS GLOBAL MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2017-2025) ($MN)
      • TABLE 61     CANCER RESEARCH GLOBAL MARKET REVENUE BY REGION, (2017-2025) ($MN)
      • TABLE 62     GENETIC TESTING GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 63     INFECTIOUS DISEASES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 64     IMMUNOLOGY GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 65     OTHER THERAPEUTICS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 66     CELL ANALYSIS GLOBAL MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 67     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 68     ACADEMIC & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 69     DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 70     PHARMA & BIOTECH COMPANIES GLOBAL MARKET REVENUE BY REGION, (2017-2025) ($MN)
      • TABLE 71     CRO’S GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 72     CELL BANKS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 73     OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 74     CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 75     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE,(2017-2025) ($MN)
      • TABLE 76     NORTH AMERICA MOLECULAR BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 77     NORTH AMERICA IMAGED BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 78     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 79     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2017-2025) ($MN)
      • TABLE 80     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2017-2025) ($MN)
      • TABLE 81     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION, (2017-2025) ($MN)
      • TABLE 82     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION, (2017-2025) ($MN)
      • TABLE 83     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2017-2025) ($MN)
      • TABLE 84     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY END-USER, (2017-2025) ($MN)
      • TABLE 85     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 86     EUROPE CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE,(2017-2025) ($MN)
      • TABLE 87     EUROPE MOLECULAR BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 88     EUROPE IMAGED BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 89     EUROPE CELL ANALYSIS MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 90     EUROPE CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2017-2025) ($MN)
      • TABLE 91     EUROPE CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2017-2025) ($MN)
      • TABLE 92     EUROPE CELL ANALYSIS MARKET REVENUE, BY PROCESS APPLICATION, (2017-2025) ($MN)
      • TABLE 93     EUROPE CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION, (2017-2025) ($MN)
      • TABLE 94     EUROPE CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2017-2025) ($MN)
      • TABLE 95     EUROPE CELL ANALYSIS MARKET REVENUE, BY END-USER, (2017-2025) ($MN)
      • TABLE 96     EUROPE CELL ANALYSIS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 97     APAC CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE,(2017-2025) ($MN)
      • TABLE 98     APAC MOLECULAR BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 99     APAC IMAGED BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE,(2017-2025) ($MN)
      • TABLE 100     APAC CELL ANALYSIS MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 101     APAC CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2017-2025) ($MN)
      • TABLE 102     APAC CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2017-2025) ($MN)
      • TABLE 103     APAC CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION, (2017-2025) ($MN)
      • TABLE 104     APAC CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION, (2017-2025) ($MN)
      • TABLE 105     APAC CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2017-2025) ($MN)
      • TABLE 106     APAC CELL ANALYSIS MARKET REVENUE, BY END-USER, (2017-2025) ($MN)
      • TABLE 107     APAC CELL ANALYSIS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 108     ROW CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE,(2017-2025) ($MN)
      • TABLE 109     ROW MOLECULAR BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 110     ROW IMAGED BASED CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE, (2017-2025) ($MN)
      • TABLE 111     ROW CELL ANALYSIS MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 112     ROW CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2017-2025) ($MN)
      • TABLE 113     ROW CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2017-2025) ($MN)
      • TABLE 114     ROW CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION, (2017-2025) ($MN)
      • TABLE 115     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION, (2017-2025)($MN)
      • TABLE 116     ROW CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2017-2025) ($MN)
      • TABLE 117     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY END-USER, (2017-2025) ($MN)
      • TABLE 118     ROW CELL ANALYSIS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 119     NEW PRODUCT LAUNCH (2018-2019)
      • TABLE 120     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2018-2019)
      • TABLE 121     MERGERS AND ACQUISITIONS (2018-2019)
      • TABLE 122     APPROVALS (2018-2019)
      • TABLE 123     BUSINESS EXPANSION (2018-2019)
      • TABLE 124     AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 125     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, (2016 -2018) ($MN)
      • TABLE 126     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 127     BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 128     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 129     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY LIFE SCIENCE SEGMENTS, (2016 -2018) ($MN)
      • TABLE 130     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 131     BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 132     BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 133     BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 134     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 135     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 136      DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 137     GE: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 138     GE: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 139     GE HEALTHCARE: TOTAL REVENUE, BY SUB SEGMENTS, (2016-2018) ($MN)
      • TABLE 140     GE: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 141     ILLUMINA, INC.: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 142     ILLUMINA, INC.: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 143     ILLUMINA, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 144     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 145     MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2016 -2018) ($MN)
      • TABLE 146     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 147     OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 148     OLYMPUS CORPORATION : TOTAL REVENUE, BY SEGMENTS (2016-2018) ($MN)
      • TABLE 149     OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2016-2018) ($MN)
      • TABLE 150     PERKINELMER, INC.: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 151     PERKINELMER, INC.: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 152     PERKINELMER, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 153     QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 154     QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 155     QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 156     THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 157     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 158     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CELL ANALYSIS GLOBAL MARKET REVENUE, BY GEOGRAPHY (2017-2025)($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: CELL ANALYSIS GLOBAL MARKET
      • FIGURE 3     CELL ANALYSIS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CELL ANALYSIS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CELL ANALYSIS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     CELL ANALYSIS GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CELL ANALYSIS GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     CELL ANALYSIS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     CELL ANALYSIS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2018) (%)
      • FIGURE 11     SINGLE-CELL ANALYSIS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2018) (%)
      • FIGURE 12     CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUES (2017-2025) ($MN)
      • FIGURE 13     MOLECULAR BASED CELL ANALYSIS GLOBAL MARKET SHARE BY REGION (2018 V/S 2025) (%)
      • FIGURE 14     MOLECULAR BASED CELL ANALYSIS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 15     IMAGE BASED CELL ANALYSIS GLOBAL MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 16     IMAGE BASED CELL ANALYSIS GLOBAL MARKET SHARE, BY REGION (2018 V/S 2025) (%)
      • FIGURE 17     CELL ANALYSIS GLOBAL MARKET SHARE, BY PRODUCT, (2018 V/S 2025) (%)
      • FIGURE 18     CELL ANALYSIS GLOBAL MARKET SHARE, BY CONSUMABLES, (2018 V/S 2025), (%)
      • FIGURE 19     CELL ANALYSIS GLOBAL MARKET SHARE, BY INSTRUMENTS, (2018), (%)
      • FIGURE 20     CELL ANALYSIS GLOBAL MARKET SHARE, BY PROCESS OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 21     CIRCULATING TUMOR CELLS GLOBAL MARKET SHARE, BY REGION (2018 V/S 2025) (%)
      • FIGURE 22     CELL ANALYSIS GLOBAL MARKET SHARE, BY FIELD OF APPLICATION (2018 V/S 2025), (%)
      • FIGURE 23     CELL ANALYSIS GLOBAL MARKET SHARE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 24     CELL ANALYSIS GLOBAL MARKET SHARE, BY END-USERS (2018 V/S 2025) (%)
      • FIGURE 25     CELL ANALYSIS MARKET GLOBAL REVENUE, BY REGION (2017-2025) ($MN)
      • FIGURE 26     CELL ANALYSIS GLOBAL MARKET REVENUE, BY GEOGRAPHY (2018) ($MN)
      • FIGURE 27     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 28     NORTH AMERICA MOLECULAR BASED CELL ANALYSIS MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 29     NORTH AMERICA IMAGE BASED CELL ANALYSIS MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 30     NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2017-2025) ($MN)
      • FIGURE 31     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY CONSUMABLES (2018 V/S 2025) (%)
      • FIGURE 32     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY INSTRUMENTS (2018) (%)
      • FIGURE 33     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY PROCESS OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 34     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY FIELD OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 35     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 36     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY END-USER (2018 V/S 2025) (%)
      • FIGURE 37     NORTH AMERICA CELL ANALYSIS MARKET SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 38     U.S CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 39     U.S. CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 40     U.S. CELL ANALYSIS APPLICATION MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 41     U.S. CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 42     U.S. CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 43     U.S. CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 44     REST OF NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017-2025) ($MN)
      • FIGURE 45     REST OF NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 46     REST OF NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 47     REST OF NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 48     REST OF NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 49     REST OF NORTH AMERICA CELL ANALYSIS MARKET REVENUE, BY ENDUSER (2018) ($MN)
      • FIGURE 50     EUROPE CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 51     EUROPE MOLECULAR BASED CELL ANALYSIS MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 52     EUROPE IMAGE BASED MARKET SHARE, BY DEVICE (2018 V/S 2025) (%)
      • FIGURE 53     EUROPE CELL ANALYSIS MARKET REVENUE, BY PRODUCTS (2017 - 2025) ($MN)
      • FIGURE 54     EUROPE CELL ANALYSIS MARKET SHARE, BY CONSUMABLES (2018 V/S 2025) (%)
      • FIGURE 55     EUROPE CELL ANALYSIS MARKET SHARE, BY INSTRUMENTS (2018 V/S 2025) (%)
      • FIGURE 56     EUROPE CELL ANALYSIS MARKET SHARE, BY PROCESS OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 57     EUROPE CELL ANALYSIS MARKET SHARE, BY FIELD OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 58     EUROPE CELL ANALYSIS MARKET SHARE, BY THERAPEUTIC AREA APPLICATION (2018 V/S 2025) (%)
      • FIGURE 59     EUROPE CELL ANALYSIS MARKET REVENUE, BY END-USER (2018 V/S 2025) (%)
      • FIGURE 60     EUROPE CELL ANALYSIS MARKET SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 61     GERMANY CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 62     GERMANY CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 63     GERMANY CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 64     GERMANY CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 65     GERMANY CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 66     GERMANY CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 67     U.K. CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 68     U.K. CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 69     U.K CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 70     U.K. CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 71     U.K. CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 72     U.K. CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 73     FRANCE CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 74     FRANCE CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 75     FRANCE CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 76     FRANCE CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025)($MN)
      • FIGURE 77     FRANCE CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 78     FRANCE CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 79     REST OF EUROPE CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 80     REST OF EUROPE CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 81     REST OF EUROPE CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 82     REST OF EUROPE CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 83     REST OF EUROPE CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 84     REST OF EUROPE CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 85     APAC CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017-2025) ($MN)
      • FIGURE 86     APAC MOLECULAR BASED CELL ANALYSIS MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 87     APAC IMAGE BASED MARKET SHARE, BY DEVICE (2018 V/S 2025) (%)
      • FIGURE 88     APAC CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2017 - 2025) ($MN)
      • FIGURE 89     APAC CELL ANALYSIS MARKET SHARE, BY CONSUMABLES (2018 V/S 2025) (%)
      • FIGURE 90     APAC CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS (2018) ($MN)
      • FIGURE 91     APAC CELL ANALYSIS MARKET SHARE, BY PROCESS OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 92     APAC CELL ANALYSIS MARKET SHARE, BY FIELD OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 93     APAC CELL ANALYSIS MARKET SHARE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 94     APAC CELL ANALYSIS MARKET SHARE, BY END-USER (2018 V/S 2025) (%)
      • FIGURE 95     APAC CELL ANALYSIS MARKET SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 96     CHINA CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 – 2025) ($MN)
      • FIGURE 97     CHINA CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 98     CHINA CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 99     CHINA CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 100     CHINA CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 101     CHINA CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 102     JAPAN CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 103     JAPAN CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 104     JAPAN CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 105     JAPAN CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 106     JAPAN CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 107     JAPAN CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 108     INDIA CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 109     INDIA CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 110     INDIA CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 111     INDIA CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 112     INDIA CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 113     INDIA CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 114     REST OF APAC CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 115     REST OF APAC CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 116     REST OF APAC CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 117     REST OF APAC CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 118     REST OF APAC CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 119     REST OF APAC CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 120     RoW CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 121     RoW MOLECULAR BASED MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 122     RoW IMAGE BASED MARKET SHARE, BY TECHNIQUE (2018 V/S 2025) (%)
      • FIGURE 123     RoW CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2017 - 2025) ($MN)
      • FIGURE 124     RoW CELL ANALYSIS MARKET SHARE, BY CONSUMABLES (2018 V/S 2025) (%)
      • FIGURE 125     RoW CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS (2018) ($MN)
      • FIGURE 126     RoW CELL ANALYSIS MARKET SHARE, BY PROCESS OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 127     RoW CELL ANALYSIS MARKET SHARE, BY FIELD OF APPLICATION (2018 V/S 2025) (%)
      • FIGURE 128     RoW CELL ANALYSIS MARKET SHARE, BY THERAPEUTIC AREA APPLICATION (2018 V/S 2025) (%)
      • FIGURE 129     RoW CELL ANALYSIS MARKET SHARE, BY END-USER (2018 V/S 2025) (%)
      • FIGURE 130     RoW CELL ANALYSIS MARKET SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 131     BRAZIL CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 132     BRAZIL CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 133     BRAZIL CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 134     BRAZIL CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 135     BRAZIL CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 136     BRAZIL CELL ANALYSIS MARKET REVENUE, BY END-USER (2018 V/S 2025) ($MN)
      • FIGURE 137     REST OF LATAM CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 138     REST OF LATAM CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 139     REST OF LATAM CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 140     REST OF LATAM CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 141     REST OF LATAM CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATIO (2018 V/S 2025) ($MN)
      • FIGURE 142     REST OF LATAM CELL ANALYSIS MARKET REVENUE, BY END-USER (2018 V/S 2025) ($MN)
      • FIGURE 143     MIDDLE EAST AND OTHERS CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2017 - 2025) ($MN)
      • FIGURE 144     MIDDLE EAST AND OTHERS CELL ANALYSIS MARKET REVENUE, BY PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 145     MIDDLE EAST AND OTHERS CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 146     MIDDLE EAST AND OTHERS CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 147     MIDDLE EAST AND OTHERS CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 148     MIDDLE EAST AND OTHERS CELL ANALYSIS MARKET REVENUE, BY END-USER (2018) ($MN)
      • FIGURE 149     KEY GROWTH STRATEGIES (2018-2019)
      • FIGURE 150     SWOT: AGILENT TECHNOLOGIES
      • FIGURE 151     SWOT: BECTON DICKINSON AND COMPANY
      • FIGURE 152     SWOT: BIO-RAD LABORATORIES INC.
      • FIGURE 153     SWOT: DANAHER CORPORATION
      • FIGURE 154     SWOT: GE HEALTHCARE
      • FIGURE 155     SWOT: ILLUMINA
      • FIGURE 156     SWOT: MERCK KGAA
      • FIGURE 157     SWOT: OLYMPUS CORPORATION
      • FIGURE 158     SWOT: PERKINELMER, INC
      • FIGURE 159     SWOT: PROMEGA CORPORATION
      • FIGURE 160     SWOT: QIAGEN N V
      • FIGURE 161     SWOT: THERMOFISHER SCIENTIFIC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     A&E LAB INSTRUMENTS (GUANGZHOU) CO., LTD
      • 2     ABBOTT LABORATORIES, INC.
      • 3     ABCAM PLC
      • 4     ABDOS LABTECH PVT, LTD.
      • 5     ABNOVA CORPORATION
      • 6     ABP BIOSCIENCES LLC
      • 7     ACTIVE MOTIF INC.
      • 8     AGILENT TECHNOLOGIES, INC.
      • 9     ALIT LIFESCIENCES CO., LTD.,
      • 10     ANALYTIK JENA AG
      • 11     APPLIED MICROARRAYS INC.
      • 12     AUSRAGEN INC.
      • 13     AVEN INC.
      • 14     AVIVA BIOSCIENCE
      • 15     BECTON DICKINSON AND COMPANY
      • 16     BGI GROUP
      • 17     BIO X CELL
      • 18     BIOCARE MEDICAL, LLC
      • 19     BIODOT INC.
      • 20     BIOFLUIDICA
      • 21     BIOLIDICS LIMITED
      • 22     BIOMERIEUX SA
      • 23     BIONEER CORPORATION
      • 24     BIO-RAD LABORATORIES INC.
      • 25     BIORON GMBH
      • 26     BIOSEARCH TECHNOLOGIES
      • 27     BIO-TECHNE CORPORATION
      • 28     BIOTEK INSTRUMENTS
      • 29     BIOVIEW LTD.
      • 30     BIOVISION, INC.
      • 31     BLUE-RAY BIOTECH
      • 32     BMS MICROSCOPES B.V.
      • 33     BROOKS LIFE SCIENCES (4TITUDE)
      • 34     BRUKER CORPORATION
      • 35     CAMBRIDGE BIOMEDICAL INC.
      • 36     CANOPUS BIOSCIENCE
      • 37     CAPP APS
      • 38     CARL ZEISS AG
      • 39     CELL SIGNALING TECHNOLOGY, INC.
      • 40     CELLNION, LLC.
      • 41     CELTIC MOLECULAR DIAGNOSTICS
      • 42     CHERRY BIOTECH
      • 43     CORNING INC.
      • 44     CREATV MICROTECH INC.
      • 45     CYTOGNOS S.L.
      • 46     DA AN GENE
      • 47     DANAHER CORPORATION
      • 48     DIAGENODE SA
      • 49     DLAB SCIENTIFIC CO.,LTD
      • 50     DOMEL D.O.O.
      • 51     ENZO LIFESCIENCES INC.
      • 52     EPPENDORF
      • 53     ETALUMA, INC
      • 54     EUROFINS SCIENTIFIC
      • 55     EXPENDEON AG
      • 56     FAVOURGEN BIOTECH CORPORATION
      • 57     FLUIDGM CORPORATION
      • 58     FLUXION BIOSCIENCES
      • 59     GE HEALTHCARE
      • 60     GENEDATA AG
      • 61     GENEMED BIOTECHNOLOGIES INC
      • 62     GENERAL BIOLOGICALS
      • 63     GYROS AB
      • 64     HAUSSER SCIENTIFIC
      • 65     HEROLAB GMBH
      • 66     HETTICH LAB TECHNOLOGY
      • 67     HIGHQU GMBH
      • 68     HOFFMANN-LA ROCHE
      • 69     HORIBA, LTD.
      • 70     IDO AMIT LAB
      • 71     ILLUMINA INC.
      • 72     IMMUNODIAGNOSTICS SYSTEMS
      • 73     JASCO ANALYTICAL INSTRUMENTS
      • 74     JENA BIOSCIENCES
      • 75     JEOL, LTD.
      • 76     KAPA BIOSYSTEMS
      • 77     KERN AND SOHN GMBH
      • 78     KEYENCE CORPORATION
      • 79     KYRATEC
      • 80     LABCON
      • 81     LABTECH INTERNATIONAL LTD
      • 82     LEXOGEN
      • 83     LGC LIMITED
      • 84     LONZA GROUP
      • 85     LUBIO SCIENCE
      • 86     LUCIGEN CORPORATION
      • 87     LUMINEX CORPORATION
      • 88     LUNGLIFE AI, INC
      • 89     LW SCIENTIFIC
      • 90     MACROGEN INC
      • 91     MAESTROGEN INC.
      • 92     MCLAB
      • 93     MEDICAL ECONET
      • 94     MEIJO TECHNO
      • 95     MERCK KGAA
      • 96     METRION BIOSCIENCES
      • 97     METTLER-TOLEDO, INC.
      • 98     MICRO-SHOT TECHNOLOGY LTD
      • 99     MILTENYIL BIOTEC GMBH
      • 100     MISSION BIO
      • 101     NANOLIVE SA
      • 102     NANOSTRING TECHNOLOGIES
      • 103     NEW ENGLAND BIOLABS
      • 104     NIKON CORPORATION
      • 105     NOVA BIOMEDICAL
      • 106     NOVOGENE CO. LTD
      • 107     NOVUS BIOLOGICS LLC
      • 108     OLYMPUS CORPORATION
      • 109     OPENTRONS
      • 110     OPTIKA S.R.L
      • 111     ORTOALRESA
      • 112     OXFORD NANOPORE TECHNOLOGIES, LTD.
      • 113     PACIFIC BIOSCIENCES
      • 114     PANAGENE
      • 115     PARK SYSTEMS
      • 116     PERKINELMER INC.
      • 117     PICOQUANT GMBH
      • 118     PRECISION FOR MEDICINE’S HOUSTON LABORATORY (APOCELL INC.)
      • 119     PROMEGA CORPORATION
      • 120     PROMOCELL
      • 121     QIAGEN N.V.
      • 122     R&D SYSTEMS
      • 123     RHEONIX
      • 124     RIGAKU CORPORATION
      • 125     RR MECHATRONICS
      • 126     SACACE BIOTECHNOLOGIES
      • 127     SARTORIUS AG
      • 128     SCIENION AG
      • 129     SCIENTIFIC SPECIALITIES INC
      • 130     SEEGENE TECHNOLOGIES
      • 131     SEIMENS HEALTHCARE
      • 132     SEMILAB GERMANY (GMBH)DANISH MICRO ENGINEERING
      • 133     SEPARATION TECHNOLOGY, INC
      • 134     SHIMADZU SCIENTIFIC INSTRUMENTS
      • 135     SIGMA LABORZENTRIFUGEN GMBH
      • 136     SINGLERON BIOTECHNOLOGIES
      • 137     SONY BIOTECHNOLOGY
      • 138     SPHERE FLUIDICS
      • 139     SPRENSON BIOSCIENCE INC.
      • 140     STEMCELL TECHNOLOGIES
      • 141     STRANDS LIFESCIENCES PVT. LTD.
      • 142     SYSMEX
      • 143     TAKARA BIO INC.
      • 144     TECAN
      • 145     THE WESTERN ELECTRIC & SCIENTIFIC WORKS
      • 146     THERMOFISHER SCIENTIFIC INC
      • 147     THORLABS
      • 148     TOMOCUBE INC.
      • 149     TOYO GOSEI CO., LTD
      • 150     TRIMGEN GENETIC DIAGNOSTICS
      • 151     VISION SCIENTIFIC CO LTD
      • 152     VISITRON SYSTEMS GMBH
      • 153     WATERS CORPORATION
      • 154     XCELRIS LABS LTD.
      • 155     YOKOGAWA ELECTRIC CORPORATION
      • 156     ZINEXTS LIFE SCIENCE CORP
      • 157     ZYMO RESEARCH
      • 158     10X GENOMICS INC